TEL AML1 FUSION OCCURS IN 28-PERCENT OF PEDIATRIC B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AND DEFINES A SUBGROUP OF PATIENTS WITH A FAVORABLE PROGNOSIS/
Sa. Shurtleff et al., TEL AML1 FUSION OCCURS IN 28-PERCENT OF PEDIATRIC B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) AND DEFINES A SUBGROUP OF PATIENTS WITH A FAVORABLE PROGNOSIS/, Blood, 86(10), 1995, pp. 2378-2378